{"filing":{"accession_number":"0001493152-26-033176","cik":"0001838716","ticker":"GNTA","company_name":"Genenta Science S.p.A.","form":"6-K","filing_date":"2026-07-14","report_date":null,"primary_document":"form6-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1838716/000149315226033176/form6-k.htm"},"events":[{"id":17838,"run_id":16000,"accession_number":"0001493152-26-033176","anchor_item_number":null,"event_type":"legal_other","event_domain":"legal","is_material":true,"confidence":0.85,"summary":"The 6-K discloses a court order by the Court of Milan (July 9, 2026) revoking a preliminary suspension order and restoring the effectiveness of a corporate purpose amendment to the Company's bylaws. This is a material legal/regulatory event affecting the Company's strategic initiatives and governance. The underlying civil action challenging the validity of shareholder resolutions remains pending, but the immediate disclosure concerns the successful outcome of the precautionary appeal, which the Court determined favored the Company's interest in maintaining the amendment's effectiveness given significant investments already made.","company_name":"Genenta Science S.p.A.","ticker":"GNTA","filing_date":"2026-07-14","form":"6-K","submitted_at":null,"items":null}],"classifications":[{"id":16455,"accession_number":"0001493152-26-033176","item_number":null,"item_title":null,"event_type":"legal_other","event_domain":"legal","is_material":true,"confidence":0.85,"reasoning":"The 6-K discloses a court order by the Court of Milan (July 9, 2026) revoking a preliminary suspension order and restoring the effectiveness of a corporate purpose amendment to the Company's bylaws. This is a material legal/regulatory event affecting the Company's strategic initiatives and governance. The underlying civil action challenging the validity of shareholder resolutions remains pending, but the immediate disclosure concerns the successful outcome of the precautionary appeal, which the Court determined favored the Company's interest in maintaining the amendment's effectiveness given significant investments already made.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-07-14T20:05:59.563574+00:00","company_name":"Genenta Science S.p.A.","ticker":"GNTA","filing_date":"2026-07-14"}]}